The effect of changes in molecular configuration on inhibitory sympathominetic action.
D008968:Molecular Conformation; D013566:Sympathomimetics
D013566:Sympathomimetics
SYMPATHOMIMETICS
J Pharmacol Exp Ther. 1947 Apr;89(4):297-305
20295509
Am J Physiol. 1952 Apr;169(1):11-21
14923856
J Physiol. 1940 Jul 24;98(3):263-82
16995203
Acta Physiol Scand. 1950 May 30;20(4):329-37
15425360
J Pharmacol Exp Ther. 1949 Feb;95(2):155-70
18111490
J Pharmacol Exp Ther. 1952 Nov;106(3):341-5
13000630
J Pharmacol Exp Ther. 1949 Apr;95 P(4):502-5
18131239
Proc Soc Exp Biol Med. 1949 Jun;71(2):220-3
18134017
Am J Physiol. 1948 Jun;153(3):586-600
18882199
J Physiol. 1940 Feb 14;97(4):453-70
16995177
J Physiol. 1935 Mar 15;83(4):483-501
16994648
J Physiol. 1927 Aug 8;63(3):201-10
16993883
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1951 Aug 16;213(3-4):283-313
14885988
Acta Physiol Scand. 1948 Jul 20;15(4):412-20
18882165
Pharmacol Rev. 1949;1(2):279-309
18147691
J Physiol. 1906 May 31;34(3):163-206
16992821
J Pharmacol Exp Ther. 1950 May;99(1):45-56
15429016
J Physiol. 1942 Nov 30;101(3):337-49
16991567
Arch Int Pharmacodyn Ther. 1950 Sep 1;83(4):602-16
14777611
J Physiol. 1910 Oct 11;41(1-2):19-59
16993040
J Am Pharm Assoc Am Pharm Assoc. 1946 Jan;35:15-8
21012557
J Pharmacol Exp Ther. 1948 Mar;92(3):207-13
18907207
J Pharmacol Exp Ther. 1948 Jul;93(3):338-45
18882139